These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 37765064)
1. Non-Anticoagulant Activities of Low Molecular Weight Heparins-A Review. Feng K; Wang K; Zhou Y; Xue H; Wang F; Jin H; Zhao W Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765064 [TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparins and their clinical applications. Hao C; Sun M; Wang H; Zhang L; Wang W Prog Mol Biol Transl Sci; 2019; 163():21-39. PubMed ID: 31030749 [TBL] [Abstract][Full Text] [Related]
3. An update on heparins at the beginning of the new millennium. Fareed J; Hoppensteadt DA; Bick RL Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802 [TBL] [Abstract][Full Text] [Related]
4. [Determination of sulfation degree of heparin and low molecular weight heparins by capillary electrophoresis]. Shen Y; Kang J Se Pu; 2020 Oct; 38(10):1238-1242. PubMed ID: 34213122 [TBL] [Abstract][Full Text] [Related]
5. Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review. Yan Y; Ji Y; Su N; Mei X; Wang Y; Du S; Zhu W; Zhang C; Lu Y; Xing XH Carbohydr Polym; 2017 Mar; 160():71-81. PubMed ID: 28115102 [TBL] [Abstract][Full Text] [Related]
7. [Determination of the anticoagulant activity of low molecular weight heparins by micellar electrokinetic chromatography combined with on-column enzymatic reaction]. Zhang M; Kang J Se Pu; 2020 Oct; 38(10):1243-1248. PubMed ID: 34213123 [TBL] [Abstract][Full Text] [Related]
8. Safety profile of different low-molecular weight heparins used at therapeutic dose. Gouin-Thibault I; Pautas E; Siguret V Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242 [TBL] [Abstract][Full Text] [Related]
9. Management of thrombotic and cardiovascular disorders in the new millenium. Fareed J; Hoppensteadt DA; Bick RL Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377 [TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711 [TBL] [Abstract][Full Text] [Related]
11. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III. Wu J; Zhang C; Mei X; Li Y; Xing XH Carbohydr Polym; 2014 Jan; 101():484-92. PubMed ID: 24299802 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins in thrombosis and cancer: emerging links. Mousa SA Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449 [TBL] [Abstract][Full Text] [Related]
13. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications. Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680 [TBL] [Abstract][Full Text] [Related]
14. Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance? Johansen KB; Balchen T Exp Hematol Oncol; 2013; 2():21. PubMed ID: 23927414 [TBL] [Abstract][Full Text] [Related]
15. Overview of low molecular weight heparins and heparinoids: basic and clinical aspects. Hirsh J Aust N Z J Med; 1992 Oct; 22(5):487-95. PubMed ID: 1280097 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulant activity and pleiotropic effects of heparin. Bal Dit Sollier C; Dillinger JG; Drouet L J Med Vasc; 2020 May; 45(3):147-157. PubMed ID: 32402428 [TBL] [Abstract][Full Text] [Related]